Electrophysiology - VANISH-2

Under the direction of Eric Crespo, MD and the Electrophysiology Department, this study will determine whether catheter ablation or antiarrhythmic drug therapy provides the most effective control of important clinical outcomes for patients with prior myocardial infarction and sustained monomorphic ventricular tachycardia.

Eligibility Criteria:

• Prior Myocardial infarction with documentation of prior injury and a prior VT event while not being treated with Class I or III antiarrhythmic drugs within the last 6 months.

For more information, contact Cynthia Marques at 860-972-5798  or email at Cynthia.marques@hhchealth.org